FEops

📍 Ghent, Belgium🗓 Founded 2009👥 38 employees💰 Last funded Nov 2023
Medical Device🌐 feops.com
Website LinkedIn
FEops cutting-edge technology transforms cardiac images into digital twins, virtual copies of the heart or its substructures. With this technology, FEops aims to improve and expand personalized management for patients with structural heart disease. It’s FEops vision that combining digital twins with AI-enabled anatomical analyses generates data-driven insights aspiring to enhance and improve structural heart disease management, spanning from patient selection, procedure planning, periprocedural guidance to patient follow-up. The CE-marked and FDA-cleared FEops HEARTguide technology enables healthcare professionals to improve both procedure efficiency and clinical outcomes. It also empowers Medtech companies to bring superior products to the market faster than ever before
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
2009
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Belgium
1
Frequently asked questions
Who invested in FEops?
FEops has 1 investors on record on gritt.io.
When did FEops last raise funding?
The most recent investment in FEops recorded on gritt.io was in November 2023.
When was FEops founded?
FEops was founded in 2009.
What industry is FEops in?
FEops operates in Medical Device. Find similar Medical Device investors on gritt.io.
Where is FEops based?
FEops is headquartered in Ghent, Belgium.